Literature DB >> 24335555

Microbial and metabolic interactions between the gastrointestinal tract and Clostridium difficile infection.

Casey M Theriot1, Vincent B Young1.   

Abstract

Antibiotics disturb the gastrointestinal tract microbiota and in turn reduce colonization resistance against Clostridium difficile. The mechanism for this loss of colonization resistance is still unknown but likely reflects structural (microbial) and functional (metabolic) changes to the gastrointestinal tract. Members of the gut microbial community shape intestinal metabolism that provides nutrients and ultimately supports host immunity. This review will discuss how antibiotics alter the structure of the gut microbiota and how this impacts bacterial metabolism in the gut. It will also explore the chemical requirements for C. difficile germination, growth, toxin production and sporulation. Many of the metabolites that influence C. difficile physiology are products of gut microbial metabolism including bile acids, carbohydrates and amino acids. To restore colonization resistance against C. difficile after antibiotics a targeted approach restoring both the structure and function of the gastrointestinal tract is needed.

Entities:  

Keywords:  Clostridium difficile; antibiotics; colonization resistance; gut metabolome; gut microbiota

Mesh:

Substances:

Year:  2013        PMID: 24335555      PMCID: PMC4049944          DOI: 10.4161/gmic.27131

Source DB:  PubMed          Journal:  Gut Microbes        ISSN: 1949-0976


  100 in total

1.  Integration of metabolism and virulence by Clostridium difficile CodY.

Authors:  Sean S Dineen; Shonna M McBride; Abraham L Sonenshein
Journal:  J Bacteriol       Date:  2010-08-13       Impact factor: 3.490

2.  Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec.

Authors:  Jacques Pépin; Nathalie Saheb; Marie-Andrée Coulombe; Marie-Eve Alary; Marie-Pier Corriveau; Simon Authier; Michel Leblanc; Geneviève Rivard; Mathieu Bettez; Valérie Primeau; Martin Nguyen; Claude-Emilie Jacob; Luc Lanthier
Journal:  Clin Infect Dis       Date:  2005-09-20       Impact factor: 9.079

3.  Regulated transcription of Clostridium difficile toxin genes.

Authors:  B Dupuy; A L Sonenshein
Journal:  Mol Microbiol       Date:  1998-01       Impact factor: 3.501

4.  Glycan foraging in vivo by an intestine-adapted bacterial symbiont.

Authors:  Justin L Sonnenburg; Jian Xu; Douglas D Leip; Chien-Huan Chen; Benjamin P Westover; Jeremy Weatherford; Jeremy D Buhler; Jeffrey I Gordon
Journal:  Science       Date:  2005-03-25       Impact factor: 47.728

Review 5.  Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics.

Authors:  G R Gibson; M B Roberfroid
Journal:  J Nutr       Date:  1995-06       Impact factor: 4.798

6.  Cefoperazone-treated mice as an experimental platform to assess differential virulence of Clostridium difficile strains.

Authors:  Casey M Theriot; Charles C Koumpouras; Paul E Carlson; Ingrid I Bergin; David M Aronoff; Vincent B Young
Journal:  Gut Microbes       Date:  2011-11-01

7.  The footprints of gut microbial-mammalian co-metabolism.

Authors:  Xiaojiao Zheng; Guoxiang Xie; Aihua Zhao; Linjing Zhao; Chun Yao; Norman H L Chiu; Zhanxiang Zhou; Yuqian Bao; Weiping Jia; Jeremy K Nicholson; Wei Jia
Journal:  J Proteome Res       Date:  2011-10-24       Impact factor: 4.466

8.  Risk factors for Clostridium difficile-associated diarrhea on an adult hematology-oncology ward.

Authors:  A H Gifford; K B Kirkland
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-12       Impact factor: 3.267

Review 9.  Bile acids: regulation of synthesis.

Authors:  John Y L Chiang
Journal:  J Lipid Res       Date:  2009-04-03       Impact factor: 5.922

10.  Carbohydrate fermentation by Clostridium difficile.

Authors:  S Nakamura; S Nakashio; K Yamakawa; N Tanabe; S Nishida
Journal:  Microbiol Immunol       Date:  1982       Impact factor: 1.955

View more
  36 in total

Review 1.  Host Microbiota Contributes to Health and Response to Disease.

Authors:  Rajeev Aurora; Thomas Sanford
Journal:  Mo Med       Date:  2015 Jul-Aug

Review 2.  Microbiota-mediated inflammation and antimicrobial defense in the intestine.

Authors:  Silvia Caballero; Eric G Pamer
Journal:  Annu Rev Immunol       Date:  2015-01-02       Impact factor: 28.527

3.  Examination of Host Phenotypes in Gambusia affinis Following Antibiotic Treatment.

Authors:  Jeanette M Carlson; Oscar Chavez; Sonali Aggarwal; Todd P Primm
Journal:  J Vis Exp       Date:  2017-02-22       Impact factor: 1.355

4.  The evaluation of GI-pill gastrointestinal electronic capsule for colonic transit test in patients with slow transit constipation.

Authors:  Yong-Bing Wang; Gang Li; Yun-Feng Wang; Yu-Jiang Ding; Guo-Zheng Yan; Ding Han; Zhi-Wu Wang; Xiao-Hui Zhao
Journal:  Int J Colorectal Dis       Date:  2019-11-22       Impact factor: 2.571

5.  Recurrent Clostridium difficile infection associates with distinct bile acid and microbiome profiles.

Authors:  J R Allegretti; S Kearney; N Li; E Bogart; K Bullock; G K Gerber; L Bry; C B Clish; E Alm; J R Korzenik
Journal:  Aliment Pharmacol Ther       Date:  2016-04-18       Impact factor: 8.171

6.  Effect of Antibiotic Treatment on the Gastrointestinal Microbiome of Free-Ranging Western Lowland Gorillas (Gorilla g. gorilla).

Authors:  Klára Vlčková; Andres Gomez; Klára J Petrželková; Christopher A Whittier; Angelique F Todd; Carl J Yeoman; Karen E Nelson; Brenda A Wilson; Rebecca M Stumpf; David Modrý; Bryan A White; Steven R Leigh
Journal:  Microb Ecol       Date:  2016-03-16       Impact factor: 4.552

Review 7.  Optimising gut colonisation resistance against Clostridium difficile infection.

Authors:  S Yuille; W G Mackay; D J Morrison; M C Tedford
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-09-09       Impact factor: 3.267

8.  Flexible Cobamide Metabolism in Clostridioides (Clostridium) difficile 630 Δerm.

Authors:  Amanda N Shelton; Xun Lyu; Michiko E Taga
Journal:  J Bacteriol       Date:  2020-01-02       Impact factor: 3.490

9.  Alteration of the murine gastrointestinal microbiota by tigecycline leads to increased susceptibility to Clostridium difficile infection.

Authors:  Christine M Bassis; Casey M Theriot; Vincent B Young
Journal:  Antimicrob Agents Chemother       Date:  2014-03-03       Impact factor: 5.191

10.  Ursodeoxycholic Acid (UDCA) Mitigates the Host Inflammatory Response during Clostridioides difficile Infection by Altering Gut Bile Acids.

Authors:  Jenessa A Winston; Alissa J Rivera; Jingwei Cai; Rajani Thanissery; Stephanie A Montgomery; Andrew D Patterson; Casey M Theriot
Journal:  Infect Immun       Date:  2020-05-20       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.